Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
dalotuzumab
(MK 0646) /
Merck (MSD), Pierre Fabre
Welcome,
Profile
Billing
Logout
44 Diseases
0 Trials
0 Trials
62 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Disease Category View
Disease View
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Breast Diseases
Breast Neoplasms
Carcinoma
Skin Diseases
Bronchial Neoplasms
Carcinoma, Bronchogenic
Carcinoma, Non-Small-Cell Lung
Colorectal Neoplasms
Lung Neoplasms
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Rectal Diseases
Adenocarcinoma
Lung Diseases
Blood Coagulation Disorders
Blood Protein Disorders
Carcinoid Tumor
Fallopian Tube Cancer
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immunoproliferative Disorders
Lymphoproliferative Disorders
Multiple Myeloma
Neoplasm Metastasis
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neoplasms, Plasma Cell
Neuroectodermal Tumors
Neuroendocrine Tumors
Neuroepithelioma
Ovarian Cancer
Ovarian Neoplasms
Paraproteinemias
Pleural Effusion
Vascular Diseases
